Mechanism of Action
Pinealon operates through epigenetic gene regulation in neurons and direct neuroprotective signaling.
Chromatin Binding and Gene Expression Modulation
Like other Khavinson peptide bioregulators, Pinealon's short sequence allows it to bind directly to gene promoter regions in neurons, particularly in cerebral cortex and hippocampus. It upregulates expression of neuroprotective genes including antioxidant enzymes (SOD, catalase), anti-apoptotic factors (Bcl-2), and neurotrophic factors (BDNF, NGF).[1]Mitochondrial Protection in Neurons
Pinealon reduces mitochondrial membrane depolarization in neurons subjected to oxidative stress, preserving the mitochondrial membrane potential that drives ATP synthesis. This mitochondrial protection is critical in neurons, which are uniquely vulnerable to energy deficit.[2]Circadian and Melatonin Regulation
Pinealon influences pinealocyte function, supporting melatonin synthesis and secretion. This circadian effect complements Epithalon's pineal-restorative action; some protocols combine both peptides for comprehensive pineal support in aging.[1]Research Overview
Neuroprotection and Aging
Most StudiedPinealon reduces neuronal death in ischemic and oxidative stress models. In aged animals, chronic Pinealon administration improves memory consolidation, reduces hippocampal neuron loss, and restores age-related deficits in spatial memory tasks. Antioxidant enzyme upregulation is consistently reproduced.[1]
Retinal and Visual Neuroprotection
Strong EvidencePinealon shows significant efficacy in models of retinal degeneration. It protects retinal ganglion cells and photoreceptors from oxidative and ischemic damage. Russian ophthalmological research has explored Pinealon for age-related macular degeneration and glaucoma-associated retinal loss.[3]
Cognitive Enhancement
Moderate EvidencePinealon improves learning and memory in aged rodent models. Combination with Epithalon in anti-aging protocols shows additive effects on cognitive performance compared to either peptide alone. BDNF upregulation is proposed as a key mechanism.[2]
Calculate your Pinealon dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Neuroprotection / cognitive | 5–10 mg | Once daily × 10 days | Subcutaneous |
| Anti-aging brain stack with Epithalon | 5 mg Pinealon + 10 mg Epithalon | Once daily × 10 days (concurrent course) | Subcutaneous |
| Conservative start | 5 mg | Once daily × 10 days | Subcutaneous |
Evening dosing preferred for circadian/melatonin alignment. Use in 10-day courses 2-3 times per year, mirroring Epithalon protocol. The Epithalon + Pinealon combination is a common Khavinson-protocol anti-aging stack addressing both telomere biology (Epithalon) and brain-specific neuroprotection (Pinealon).
Research protocols only. Not medical advice.
Peptide Interactions
Safety Profile
Pinealon has the favorable safety profile typical of the Khavinson short peptide bioregulator series.
No significant adverse effects: Long-term rodent studies and Russian clinical observational data show no toxicity or hematological changes at research doses.
Cycle-based use: All research uses 10-day courses rather than continuous daily dosing. Long-term continuous dosing data is lacking.
No FDA approval: Not approved in the US or EU. Used in Russian anti-aging medicine. Research compound status in Western markets.
References
- [1]Khavinson VKh, et al. "Peptide regulation of gene expression and protein synthesis in retina." Bull Exp Biol Med. 2003;136(5):474-476.
- [2]Khavinson VKh, et al. "Geroprotective effects of tripeptides in rodents." Arch Gerontol Geriatr. 2012;55(1):99-104.
- [3]Khavinson VKh, et al. "Effect of Pinealon on the retina in aging." Bull Exp Biol Med. 2007;144(4):526-529.